Ensysce Biosciences Q2 EPS $(0.98) Up From $(57.60) YoY, Sales $490.47K Up From $207.47K YoY
Portfolio Pulse from Happy Mohamed
Ensysce Biosciences reported Q2 losses of $(0.98) per share, a 98.3% increase from $(57.60) per share YoY. The company's sales also increased by 136.41% to $490.47K from $207.47K YoY.
August 11, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ensysce Biosciences reported a significant decrease in losses and a substantial increase in sales YoY.
The company reported a significant decrease in losses and a substantial increase in sales compared to the same period last year. This indicates a positive financial performance and could potentially lead to a positive reaction in the stock market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100